Smith Stephanie, Hwang Ji-Young, Banerjee Soma, Majeed Anju, Gupta Amitabha, Myung Kyungjaem
Genome Instability Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9039-44. doi: 10.1073/pnas.0403093101. Epub 2004 Jun 7.
Different types of gross chromosomal rearrangements (GCRs), including translocations, interstitial deletions, terminal deletions with de novo telomere additions, and chromosome fusions, are observed in many cancers. Multiple pathways, such as S-phase checkpoints, DNA replication, recombination, chromatin remodeling, and telomere maintenance that suppress GCRs have been identified. To experimentally expand our knowledge of other pathway(s) that suppress GCRs, we developed a generally applicable genome-wide screening method. In this screen, we identified 10 genes (ALO1, CDC50, CSM2, ELG1, ESC1, MMS4, RAD5, RAD18, TSA1, and UFO1) that encode proteins functioning in the suppression of GCRs. Moreover, the breakpoint junctions of GCRs from these GCR mutator mutants were determined with modified breakpoint-mapping methods. We also identified nine genes (AKR1, BFR1, HTZ1, IES6, NPL6, RPL13B, RPL27A, RPL35A, and SHU2) whose mutations generated growth defects with the pif1Delta mutation. In addition, we found that some of these mutations changed the telomere size.
在许多癌症中都观察到了不同类型的染色体大片段重排(GCRs),包括易位、中间缺失、伴有新生端粒添加的末端缺失以及染色体融合。已经确定了多种抑制GCRs的途径,如S期检查点、DNA复制、重组、染色质重塑和端粒维持。为了通过实验扩展我们对其他抑制GCRs途径的认识,我们开发了一种普遍适用的全基因组筛选方法。在这个筛选中,我们鉴定出了10个基因(ALO1、CDC50、CSM2、ELG1、ESC1、MMS4、RAD5、RAD18、TSA1和UFO1),它们编码在抑制GCRs中起作用的蛋白质。此外,使用改良的断点映射方法确定了来自这些GCR突变体突变体的GCRs的断点连接。我们还鉴定出了9个基因(AKR1、BFR1、HTZ1、IES6、NPL6、RPL13B、RPL27A、RPL35A和SHU2),它们的突变与pif1Delta突变一起产生生长缺陷。此外,我们发现其中一些突变改变了端粒大小。